Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study
NCT01715155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 171
Last updated 2013-08-22
Summary
The purpose of this study is to evaluate the incidence rate of progression of disease, to describe the diagnostic and clinical management in patients with Metastatic Breast Cancer in the clinical practice in Bulgaria.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- Bulgaria
Study Locations
More Related Trials
-
Observational Study on the Treatment of Patients With Metastatic Breast Cancer
NCT06676436 ·Status: COMPLETED
-
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
NCT02340221 ·Status: TERMINATED ·Phase: PHASE3
-
Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting
NCT02546232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Faslodex Registry: Fulvestrant in Current Clinical Practice
NCT00735215 ·Status: COMPLETED
-
Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice
NCT02655159 ·Status: TERMINATED
-
Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients
NCT00429247 ·Status: COMPLETED ·Phase: PHASE2
-
Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer
NCT02530411 ·Status: UNKNOWN ·Phase: PHASE2
-
Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer
NCT02690480 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial
NCT00001250 ·Status: COMPLETED ·Phase: PHASE2
-
Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer
NCT01948726 ·Status: COMPLETED ·Phase: NA
-
Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer
NCT07021846 ·Status: RECRUITING ·Phase: NA
-
Fulvestrant in Metastatic Breast Cancer
NCT03591549 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)
NCT00927511 ·Status: UNKNOWN ·Phase: PHASE2
-
HR+/HER2- Advanced Breast Cancer and Endocrine Resistance
NCT03322215 ·Status: TERMINATED ·Phase: PHASE2
-
Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland
NCT01630226 ·Status: UNKNOWN ·Phase: PHASE2
-
A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer
NCT02216786 ·Status: COMPLETED ·Phase: PHASE2
-
Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
NCT01142401 ·Status: COMPLETED ·Phase: PHASE2
-
Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC
NCT07047755 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients
NCT00432172 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
NCT06800612 ·Status: RECRUITING
-
A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer
NCT02144012 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Neoadjuvant Chemotherapy of Breast Cancer
NCT00830544 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer
NCT01876251 ·Status: TERMINATED ·Phase: PHASE1
-
Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer
NCT01392586 ·Status: TERMINATED ·Phase: PHASE3
-
Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in Turkey
NCT04770129 ·Status: COMPLETED